Scinovex
articleTop 1% cited

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

International Journal of Radiation Oncology*Biology*Physics · 2001 · Vol. 50(5) · pp. 1243–1252
Miljenko V. PilepichKathryn WinterMadhu J. JohnJ MesićWilliam T. SausePhillip RubinC.A. LawtonMitchell MachtayDavid J. Grignon
Prostate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchAdvanced Radiotherapy TechniquesMedicineFlutamideRadiation therapyUrologyRegimenAndrogen deprivation therapyGoserelinInternal medicineProstate cancerRandomized controlled trial

MeSH terms

AdenocarcinomaAndrogen AntagonistsCause of DeathCombined Modality TherapyFlutamideFollow-Up StudiesHumansGonadotropin-Releasing HormoneMaleNeoplasm InvasivenessNeoplasm Recurrence, LocalNeoplasm StagingProstatic NeoplasmsRadiotherapy, High-EnergyLife Tables
Citations
774
FWCI
42.70
field-weighted impact
References
18
Percentile
100%
vs. same field & year
Citations per year
Cited by
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.